At a glance
- Originator Esteve
- Class Antidepressants; Pyrazoles; Small molecules
- Mechanism of Action Substance P release inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 03 Jun 2005 Phase-II clinical trials in Depression in United Kingdom (unspecified route)
- 16 Apr 2003 This compound is still in active development
- 24 Jul 2001 Phase-I clinical trials for Depression in United Kingdom (Unknown route)